Chronic treatment with a serotonin2 receptor (5-HT2R) agonist modulates the behavioral and cellular response to (+)-3,4- methylenedioxymethamphetamine [(+)-MDMA]

Drug and Alcohol Dependence

Volumn 81, Issue 2, 2006, Pages 117-127

  Ross, Julie D ^a   Herin, David V ^a   Frankel, Paul S ^a   Thomas, Mary L ^a   Cunningham, Kathryn A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

DOI; Hyperactivity; MDMA; MK 212; Sensitization; Serotonin receptor

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; PROTEIN C FOS; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN AGONIST;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; ENANTIOMER; HYPERACTIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOCOMOTION; MALE; NERVE CELL EXCITABILITY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; SEROTONIN RELEASE;

AMPHETAMINES; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; DOWN-REGULATION; HALLUCINOGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT2; SEROTONIN AGENTS; SEROTONIN AGONISTS;

ANIMALIA;

EID: 29244482574     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.06.004     Document Type: Article

References (69)

1. J. Arnt Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats Pharmacol. Toxicol. 64 1989 165 172
2. A. Auclair, G. Blanc, J. Glowinski, and J. Tassin Role of serotonin2A receptors in the d-amphetamine-induced release of dopamine: comparison with previous data on α1b-adrenergic receptors J. Neurochem. 91 2004 318 326
3. L.E. Baker, T.B. Virden, M.E. Miller, and C.L. Sullivan Time course analysis of the discriminative stimulus effects of the optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) Pharmacol. Biochem. Behav. 58 1997 505 516
4. M.G. Bankson, and K.A. Cunningham Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors Neuropsychopharmacology 26 2002 40 52
5. G. Battaglia, B.P. Brooks, C. Kulsakdinun, and E.B. de Souza Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites Eur. J. Pharmacol. 149 1988 159 163
6. C. Bishop, J.L. Tessmer, T. Ullrich, K.C. Rice, and P.D. Walker Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism J. Pharmacol. Exp. Ther. 310 2004 687 694
7. C.W. Bradberry, and R.H. Roth Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis Neurosci. Lett. 103 1989 97 102
8. M.J. Bubar, and K.A. Cunningham Repeated 5-HT2CR agonist induces persistent enhancement of (+)-MDMA-induced hyperactivity despite recovery of 5-HT2CR sensitivity Behav. Pharmacol. 14 2003 64
9. M.J. Bubar, K.M. Pack, P.S. Frankel, and K.A. Cunningham Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA Psychopharmacology (Berl.) 173 2004 326 336
10. E.J. Bull, P.H. Hutson, and K.C. Fone Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT(2A) receptor responsivity Neuropharmacology 46 2004 202 210
11. P.M. Callahan, R. De La Garza, and K.A. Cunningham Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems Pharmacol. Biochem. Behav. 57 1997 601 607
12. C.W. Callaway, L.L. Wing, and M.A. Geyer Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats J. Pharmacol. Exp. Ther. 254 1990 456 464
13. D. Crespi, T. Mennini, and M. Gobbi Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine Br. J. Pharmacol. 121 1997 1735 1743
14. E.J. Curran, H. Akil, and S.J. Watson Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals Neurochem. Res. 21 1996 1425 1435
15. N.A. Darmani, B.R. Martin, and R.A. Glennon Withdrawal from chronic treatment with (+/-)-causes super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in mice Eur. J. Pharmacol. 186 1990 115 118
16. V. Di Matteo, G. Di Giovanni, M. Di Mascio, and E. Esposito Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors. Brain Res. 865 2000 85 90
17. M.D. Doherty, and V.M. Pickel Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area Brain Res. 864 2000 176 185
18. W.E. Fantegrossi, T. Ullrich, K.C. Rice, J.H. Woods, and G. Winger 3,4-Methylenedioxymethamphetamine (MDMA "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement Psychopharmacology (Berl.) 161 2002 356 364
19. W.E. Fantegrossi, T. Godlewski, R.L. Karabenick, J.M. Stephens, T. Ullrich, K.C. Rice, and J.H. Woods Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice Psychopharmacology (Berl.) 166 2003 202 211
20. M. Filip, M.J. Bubar, and K.A. Cunningham Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses J. Pharmacol. Exp. Ther. 310 2004 1246 1254
21. M. Filip, E. Przegalinski, and K.A. Cunningham Characterization of the roles for serotonin (5-HT) 5-HT2A receptors (5-HT2AR) in the ventral tegmental area and prefrontal cortex in spontaneous activity and cocaine-induced hyperactivity International Serotonin Club Meeting Porto, Portugal 2004
22. P.J. Fletcher, K.M. Korth, S.R. Robinson, and G.B. Baker Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement Psychopharmacology (Berl.) 162 2002 282 291
23. P.S. Frankel, and K.A. Cunningham The hallucinogen d-lysergic acid diethylamide (d-LSD) induces the immediate-early gene c-Fos in rat forebrain. Brain Res. 958 2002 251 260
24. L.H. Gold, C.B. Hubner, and G.F. Koob A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA Psychopharmacology (Berl.) 99 1989 40 47
25. L.H. Gold, G.F. Koob, and M.A. Geyer Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats J. Pharmacol. Exp. Ther. 247 1988 547 555
26. J.A. Gray, B.A. Compton-Toth, and B.L. Roth Identification of two serine residues essential for agonist-induced 5-HT2A receptor desensitization Biochemistry 42 2003 10853 10862
27. D.V. Herin, S. Liu, T. Ullrich, K.C. Rice, and K.A. Cunningham Role of the serotonin 5-HT(2A) receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine Psychopharmacology (Berl.) 178 2005 505 513
28. M. Hiramatsu, and A.K. Cho Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study Neuropharmacology 29 1990 269 275
29. J. Ichikawa, and H.Y. Meltzer DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum Brain Res. 698 1995 204 208
30. M. Jaber, M. Cador, B. Dumartin, E. Normand, L. Stinus, and B. Bloch Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons Neuroscience 65 1995 1041 1050
31. P.W. Kalivas, P. Duffy, and S.R. White MDMA elicits behavioral and neurochemical sensitization in rats Neuropsychopharmacology 18 1998 469 479
32. J.H. Kehne, H.J. Ketteler, T.C. McCloskey, C.K. Sullivan, M.W. Dudley, and C.J. Schmidt Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats Neuropsychopharmacology 15 1996 116 124
33. N. Khorana, M.R. Pullagurla, R. Young, and R.A. Glennon Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization Drug Alcohol Depend. 74 2004 281 287
34. T. Kuroki, H.Y. Meltzer, and J. Ichikawa 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens Brain Res. 972 2003 216 221
35. I. Lucki, and N. Minugh-Purvis Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex Brain Res. 420 1987 403 406
36. I. Lucki, H.R. Ward, and A. Frazer Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity J. Pharmacol. Exp. Ther. 249 1989 155 164
37. A.C. McCreary, M.G. Bankson, and K.A. Cunningham Pharmacological studies of the acute and chronic effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/ 1D) receptors J. Pharmacol. Exp. Ther. 290 1999 965 973
38. L.R. McMahon, and K.A. Cunningham Antagonism of 5-hydroxytryptamine2A receptors attenuates the behavioral effects of cocaine in rats J. Pharmacol. Exp. Ther. 297 2001 357 363
39. L.R. McMahon, M. Filip, and K.A. Cunningham Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors J. Neurosci. 21 2001 7781 7787
40. G. Mengod, M. Pompeiano, M.I. Martinez-Mir, and J.M. Palacios Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites Brain Res. 524 1990 139 143
41. M.J. Morgan Ecstasy (MDMA): a review of its possible persistent psychological effects Psychopharmacology (Berl.) 152 2000 230 248
42. A.E. Morgan, B. Horan, S.L. Dewey, and C.R. Ashby Jr. Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study Eur. J. Pharmacol. 331 1997 R1 R3
43. National Research Council, 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
44. W. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1998 Academic Press San Diego, CA
45. A. Pazos, R. Cortes, and J.M. Palacios Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors Brain Res. 346 1985 231 249
46. A. Pazos, and J.M. Palacios Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors Brain Res. 346 1985 205 230
47. E. Ratzenboeck, A. Saria, N. Kriechbaum, and G. Zernig Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats Pharmacology 62 2001 138 144
48. T.E. Robinson, and K.C. Berridge The neural basis of drug craving: an incentive-sensitization theory of addiction Brain Res. Brain Res. Rev. 18 1993 247 291
49. B.L. Roth, W.K. Kroeze, S. Patel, and E. Lopez The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrasment of riches? Neuroscientist 6 2000 252 262
50. G. Rudnick, and S.C. Wall The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release Proc. Natl. Acad. Sci. USA 89 1992 1817 1821
51. S.M. Sagar, F.R. Sharp, and T. Curran Expression of c-fos protein in brain: metabolic mapping at the cellular level Science 240 1988 1328 1331
52. U. Scheffel, J.R. Lever, M. Stathis, and G.A. Ricaurte Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors Neuropharmacology 31 1992 881 893
53. S. Schenk, D. Gittings, M. Johnstone, and E. Daniela Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats Psychopharmacology (Berl.) 169 2003 21 27
54. C.J. Schmidt, G.M. Fadayel, C.K. Sullivan, and V.L. Taylor 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine Eur. J. Pharmacol. 223 1992 65 74
55. M. Shannon, G. Battaglia, R.A. Glennon, and M. Titeler 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2- aminopropane (2,5-DMA) Eur. J. Pharmacol. 102 1984 23 29
56. D. Sheskin Handbook of Parametric and Nonparametric Statistical Procedures. 2000 Chapman & Hall/CRC Boca Raton
57. A.T. Shulgin, A. Shulgin, and P. Jacob III Central nervous system (CNS) activity of two new psychoactive compounds J. Psychoactive Drugs 23 1991 95 96
58. R.L. Smith, R.J. Barrett, and E. Sanders-Bush Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor Psychopharmacology (Berl.) 144 1999 248 254
59. L.J. Spanos, and B.K. Yamamoto Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat Pharmacol. Biochem. Behav. 32 1989 835 840
60. C.P. Stephenson, G.E. Hunt, A.N. Topple, and I.S. McGregor The distribution of 3,4-methylenedioxymethamphetamine "ecstasy"-induced c-fos expression in rat brain Neuroscience 92 1999 1011 1023
61. D.M. Stone, D.C. Stahl, G.R. Hanson, and J.W. Gibb The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain Eur. J. Pharmacol. 128 1986 41 48
62. M.E. Tancer, and C.E. Johanson The subjective effects of MDMA and mCPP in moderate MDMA users Drug Alcohol Depend. 65 2001 97 101
63. D. Van Oekelen, A. Megens, T. Meert, W.H.M.L. Luyten, and J.E. Leysen Role of 5-HT2 receptors in the tryptamine-induced 5-HT syndrome in rats Behav. Pharmacol. 13 2002 313 318
64. D. Van Oekelen, W.H. Luyten, and J.E. Leysen 5-HT2A and 5-HT2C receptors and their atypical regulation properties Life Sci. 72 2003 2429 2449
65. F.J. White, and P.W. Kalivas Neuroadaptations involved in amphetamine and cocaine addiction Drug Alcohol Depend. 51 1998 141 153
66. S.R. White, G.C. Harris, K.M. Imel, and M.J. Wheaton Inhibitory effects of dopamine and methylenedioxymethamphetamine (MDMA) on glutamate-evoked firing of nucleus accumbens and caudate/putamen cells are enhanced following cocaine self-administration Brain Res. 681 1995 167 176
67. D.L. Willins, and H.Y. Meltzer Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head twitch response in rats J. Pharmacol. Exp. Ther. 282 1997 699 706
68. Q. Yan, M.E. Reith, and S. Yan Enhanced accumbal dopamine release following 5-HT(2A) receptor stimulation in rats pretreated with intermittent cocaine Brain Res. 863 2000 254 258
69. Q.S. Yan Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission Brain Res. Bull. 51 2000 75 81